Physician

James Udell, MD

According to 2025 Medicare claims, James Udell, MD (NPI: 1770520827) practices rheumatology in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Philadelphia, PA. This provider's primary affiliated billing organization is ARTHRITIS GROUP PC (NPI: 1700823838; TIN: 232846614) and primary practice location at 19152-3303.

Udell's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 506 traditional Medicare patients, billed 62,162 HCPCS/CPT codes, and received $909,891 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 2,357 prescription claims across 375 beneficiaries totaling $1,008,421 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 77 records totaling $1,734. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $2,622,954 to $909,891. In contrast, Part D prescription costs have risen steadily, from $642,342 to $1,008,421. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.4M$2.7M2015 Medicare payment: $2,622,954 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,746,223 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,734,745 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,384,251 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,069,576 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,238,670 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,753,752 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,368,372 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,106,733 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $909,891 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015561118,042$2,622,954
2016603110,101$2,746,223
2017639107,255$2,734,745
201864885,106$2,384,251
201961177,140$2,069,576
2020609118,007$2,238,670
202158895,566$1,753,752
202254286,905$1,368,372
202354267,980$1,106,733
202450662,162$909,891

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$597K$1.2M2015 Drug cost: $642,342 (USD; Tot_Drug_Cst)2016 Drug cost: $834,684 (USD; Tot_Drug_Cst)2017 Drug cost: $769,844 (USD; Tot_Drug_Cst)2018 Drug cost: $850,227 (USD; Tot_Drug_Cst)2019 Drug cost: $1,116,056 (USD; Tot_Drug_Cst)2020 Drug cost: $1,193,371 (USD; Tot_Drug_Cst)2021 Drug cost: $1,077,969 (USD; Tot_Drug_Cst)2022 Drug cost: $1,075,669 (USD; Tot_Drug_Cst)2023 Drug cost: $1,115,133 (USD; Tot_Drug_Cst)2024 Drug cost: $1,008,421 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154263,413$642,342
20164553,528$834,684
20174673,326$769,844
20185033,497$850,227
20194943,106$1,116,056
20204132,870$1,193,371
20214162,629$1,077,969
20223832,437$1,075,669
20233802,290$1,115,133
20243752,357$1,008,421

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
96413Administration of chemotherapy into vein, 1 hour or less113241$100
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more282801$99
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more208407$70
20610Aspiration and/or injection of fluid from large joint80171$64
J0897Injection, denosumab, 1 mg817,620$20

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab391,232$292,659
Humira PenAdalimumab341,008$236,612
HumiraAdalimumab13364$86,718
Humira(Cf)Adalimumab11308$74,626
ProliaDenosumab183,060$30,920

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.77$1,734ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for James Udell, MD?

Tedicare shows public-source Medicare data for James Udell, MD (NPI 1770520827), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James Udell, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to James Udell, MD?

James Udell, MD is linked to ARTHRITIS GROUP PC (billing NPI 1700823838) in the available physician profile data.

Does James Udell, MD have Open Payments data?

James Udell, MD has 77 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.